UBS analyst Ashwani Verma raised the price target on United Therapeutics Corp. (NASDAQ: UTHR) to $560.00 (from $415.00) while maintaining ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE